| Literature DB >> 29730239 |
Brian Butala1, Michael Busada2, Daniel Cormican3.
Abstract
Malignant hyperthermia is a potentially life-threatening hypermetabolic disorder, often induced by exposure to volatile anesthetics and succinylcholine. There are few reports of malignant hyperthermia during cardiopulmonary bypass. Here the authors review available literature including case reports of malignant hyperthermia and cardiopulmonary bypass and discuss the potential implications of malignant hyperthermia diagnosis and management as it applies to cardiac surgery.Entities:
Keywords: cardiopulmonary bypass; dantrolene; malignant hyperthermia; ryanodine receptor
Mesh:
Substances:
Year: 2018 PMID: 29730239 DOI: 10.1053/j.jvca.2018.03.029
Source DB: PubMed Journal: J Cardiothorac Vasc Anesth ISSN: 1053-0770 Impact factor: 2.628